Ispecimen Inc (ISPC)

$0.34 +0.03 (9.85%)
Market Cap 3.02M
Revenue (ttm) 9.29M
Net Income (ttm) -12.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -134.55%
Debt to Equity Ratio 0.00
Volume 2,479,200
Avg Vol 1,264,332
Day's Range N/A - N/A
Shares Out 9.77M
Stochastic %K 65%
Beta 1.83
Analysts Strong Buy
Price Target $4.25

Company Profile

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal m...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 301 6700
Address:
8 Cabot Road, Woburn, United States
ieatbaguette
ieatbaguette Jan. 13 at 8:00 PM
Fake company fake news fake Solana $ISPC prob going to 100$
0 · Reply
michaelmason
michaelmason Jan. 13 at 4:06 PM
$ISPC anybody know what’s going on? Is this the solana news
1 · Reply
Hazza007
Hazza007 Jan. 13 at 3:53 PM
$ISPC load up ⬆️
0 · Reply
ArlendMcfarland
ArlendMcfarland Jan. 13 at 3:43 PM
$ISPC just the start
0 · Reply
ak291
ak291 Jan. 13 at 9:02 AM
$ISPC bullish
0 · Reply
harg
harg Jan. 9 at 4:43 PM
$ISPC Third or so time this “consultant “ has been “hired “ for similar amounts and a non specific performance contract. Check out their “office “ and lack of track record. Hmmmm.
1 · Reply
PaulLaurent
PaulLaurent Jan. 9 at 6:38 AM
🌅 4:00am EST Watchlist $OPAD – AH runner. Watch VWAP holds, liquidity build, and prior HOD reclaims; scalp-first with tight risk. $LRHC – AH runner. Thin tape—respect halts; look for higher-lows and clean pivot reclaims. $CETX – Completed Invocon acquisition; launching aerospace & defense line. Event-driven; monitor follow-up filings and financing mechanics. $ISPC – Potential multi-day runner. Favor VWAP/pivot reclaims and quick trims into spikes. $CGTL – Potential multi-day runner. Seek volume persistence and prior HOD tests; keep risk tight on fades. Tone: Corporate actions and AH momentum lead. Favor VWAP/pivot reclaims, scale into strength, and protect gains.
1 · Reply
Rippinggg11
Rippinggg11 Jan. 9 at 2:19 AM
Fridays watchlist 📈 part two $BETR $ISPC $UUUU $UEC
0 · Reply
SupremeTrader93
SupremeTrader93 Jan. 8 at 3:25 PM
$NVVE got some here at low of day $UAVS $ISPC $JTAI
0 · Reply
Sw1ngb0t
Sw1ngb0t Jan. 8 at 1:26 PM
$ISPC $1.84 was my target. hit
0 · Reply
Latest News on ISPC
E.F. Hutton & Co. Acts as Exclusive Placement Agent in iSpecimen Inc.'s ~$5.5 Million Private Placement

Jan 6, 2026, 10:00 AM EST - 7 days ago

E.F. Hutton & Co. Acts as Exclusive Placement Agent in iSpecimen Inc.'s ~$5.5 Million Private Placement

iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions

Sep 4, 2025, 4:05 PM EDT - 4 months ago

iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions

iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform

Aug 21, 2025, 8:00 AM EDT - 5 months ago

iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform

iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow

Aug 7, 2025, 4:05 PM EDT - 5 months ago

iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market

Aug 4, 2025, 6:45 PM EDT - 5 months ago

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market

iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market

Jul 31, 2025, 4:06 PM EDT - 5 months ago

iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

Jul 28, 2025, 4:35 PM EDT - 6 months ago

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

Jul 28, 2025, 4:30 PM EDT - 6 months ago

Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

Jul 25, 2025, 1:53 PM EDT - 6 months ago

iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

Jul 24, 2025, 8:30 AM EDT - 6 months ago

iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

Jan 16, 2025, 4:01 PM EST - 1 year ago

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

Dec 20, 2024, 8:30 AM EST - 1 year ago

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

Dec 13, 2024, 7:30 AM EST - 1 year ago

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

iSpecimen Appoints Robert Lim as CEO and Director

Dec 12, 2024, 5:11 PM EST - 1 year ago

iSpecimen Appoints Robert Lim as CEO and Director

iSpecimen Named Top Competitor in $4.4 Billion USD Market

Nov 8, 2024, 7:30 AM EST - 1 year ago

iSpecimen Named Top Competitor in $4.4 Billion USD Market

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually

Nov 7, 2024, 7:30 AM EST - 1 year ago

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

Oct 31, 2024, 3:07 PM EDT - 1 year ago

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

Oct 30, 2024, 8:30 AM EDT - 1 year ago

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

iSpecimen Secures $1 Million Loan; Appoints Three New Board Members

Sep 26, 2024, 7:30 AM EDT - 1 year ago

iSpecimen Secures $1 Million Loan; Appoints Three New Board Members

iSpecimen Announces 1-for-20 Reverse Stock Split

Sep 11, 2024, 4:30 PM EDT - 1 year ago

iSpecimen Announces 1-for-20 Reverse Stock Split

iSpecimen Inc. (ISPC) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 7:14 AM EDT - 1 year ago

iSpecimen Inc. (ISPC) Q2 2024 Earnings Call Transcript

iSpecimen Reports Second Quarter 2024 Results

Aug 6, 2024, 7:30 AM EDT - 1 year ago

iSpecimen Reports Second Quarter 2024 Results

iSpecimen Inc. (ISPC) Q1 2024 Earnings Call Transcript

May 12, 2024, 8:24 AM EDT - 1 year ago

iSpecimen Inc. (ISPC) Q1 2024 Earnings Call Transcript

iSpecimen Reports First Quarter 2024 Results

May 7, 2024, 7:30 AM EDT - 1 year ago

iSpecimen Reports First Quarter 2024 Results

iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024

Apr 25, 2024, 8:00 AM EDT - 1 year ago

iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024

iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 10:40 AM EDT - 1 year ago

iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript

iSpecimen Reports Full Year 2023 Results

Mar 14, 2024, 8:00 AM EDT - 1 year ago

iSpecimen Reports Full Year 2023 Results

iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call

Mar 12, 2024, 7:07 PM EDT - 2 years ago

iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call

iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024

Mar 5, 2024, 4:30 PM EST - 2 years ago

iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024

iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research

Jan 23, 2024, 7:30 AM EST - 2 years ago

iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research

iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024

Jan 18, 2024, 8:11 AM EST - 2 years ago

iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024

iSpecimen Strengthens Global Oncology Biospecimen Offering

Dec 7, 2023, 7:30 AM EST - 2 years ago

iSpecimen Strengthens Global Oncology Biospecimen Offering

iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript

Nov 3, 2023, 4:39 PM EDT - 2 years ago

iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript

iSpecimen Reports Third Quarter 2023 Financial and Operating Results

Nov 2, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Reports Third Quarter 2023 Financial and Operating Results

iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research

Oct 26, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research

iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially

Oct 23, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially

iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers

Sep 28, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers

iSpecimen Expands Provider Network to Enhance Support for Women's Health Research

Sep 13, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Expands Provider Network to Enhance Support for Women's Health Research

iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability

Sep 6, 2023, 4:05 PM EDT - 2 years ago

iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability

Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX)

Sep 6, 2023, 7:36 AM EDT - 2 years ago

Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX)

BIVI OMIC

iSpecimen Launches New Virtual Cancer Sequencing Procurement Program

Aug 30, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Launches New Virtual Cancer Sequencing Procurement Program

iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers

Aug 16, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers

iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers

Aug 9, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers

iSpecimen Inc. (ISPC) Q2 2023 Earnings Call Transcript

Aug 5, 2023, 10:22 AM EDT - 2 years ago

iSpecimen Inc. (ISPC) Q2 2023 Earnings Call Transcript

iSpecimen Reports Second Quarter 2023 Financial and Operating Results

Aug 2, 2023, 7:00 AM EDT - 2 years ago

iSpecimen Reports Second Quarter 2023 Financial and Operating Results

iSpecimen to Report Second Quarter 2023 Results on August 2, 2023

Jul 25, 2023, 7:30 AM EDT - 2 years ago

iSpecimen to Report Second Quarter 2023 Results on August 2, 2023

Thirteen New Biospecimen Suppliers Added to iSpecimen's Proprietary Provider Network

Jul 6, 2023, 7:30 AM EDT - 2 years ago

Thirteen New Biospecimen Suppliers Added to iSpecimen's Proprietary Provider Network

iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on June 1, 2023

May 23, 2023, 7:30 AM EDT - 2 years ago

iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on June 1, 2023

iSpecimen Inc. (ISPC) Q1 2023 Earnings Call Transcript

May 6, 2023, 6:25 PM EDT - 2 years ago

iSpecimen Inc. (ISPC) Q1 2023 Earnings Call Transcript

iSpecimen Reports First Quarter 2023 Results

May 4, 2023, 7:00 AM EDT - 2 years ago

iSpecimen Reports First Quarter 2023 Results

ieatbaguette
ieatbaguette Jan. 13 at 8:00 PM
Fake company fake news fake Solana $ISPC prob going to 100$
0 · Reply
michaelmason
michaelmason Jan. 13 at 4:06 PM
$ISPC anybody know what’s going on? Is this the solana news
1 · Reply
Hazza007
Hazza007 Jan. 13 at 3:53 PM
$ISPC load up ⬆️
0 · Reply
ArlendMcfarland
ArlendMcfarland Jan. 13 at 3:43 PM
$ISPC just the start
0 · Reply
ak291
ak291 Jan. 13 at 9:02 AM
$ISPC bullish
0 · Reply
harg
harg Jan. 9 at 4:43 PM
$ISPC Third or so time this “consultant “ has been “hired “ for similar amounts and a non specific performance contract. Check out their “office “ and lack of track record. Hmmmm.
1 · Reply
PaulLaurent
PaulLaurent Jan. 9 at 6:38 AM
🌅 4:00am EST Watchlist $OPAD – AH runner. Watch VWAP holds, liquidity build, and prior HOD reclaims; scalp-first with tight risk. $LRHC – AH runner. Thin tape—respect halts; look for higher-lows and clean pivot reclaims. $CETX – Completed Invocon acquisition; launching aerospace & defense line. Event-driven; monitor follow-up filings and financing mechanics. $ISPC – Potential multi-day runner. Favor VWAP/pivot reclaims and quick trims into spikes. $CGTL – Potential multi-day runner. Seek volume persistence and prior HOD tests; keep risk tight on fades. Tone: Corporate actions and AH momentum lead. Favor VWAP/pivot reclaims, scale into strength, and protect gains.
1 · Reply
Rippinggg11
Rippinggg11 Jan. 9 at 2:19 AM
Fridays watchlist 📈 part two $BETR $ISPC $UUUU $UEC
0 · Reply
SupremeTrader93
SupremeTrader93 Jan. 8 at 3:25 PM
$NVVE got some here at low of day $UAVS $ISPC $JTAI
0 · Reply
Sw1ngb0t
Sw1ngb0t Jan. 8 at 1:26 PM
$ISPC $1.84 was my target. hit
0 · Reply
suredubb
suredubb Jan. 8 at 8:20 AM
$ISPC Dude… bears are saying anything they can.. let’s get the announcement they hired a consulting firm for, at the price tag of 2,000,000 greed days ahead
1 · Reply
DDUDDU
DDUDDU Jan. 8 at 4:38 AM
$ISPC We bring you the news you’ve been waiting for. ISPC is currently suffering from severe financial difficulties and appears to have reached a point where it cannot even pay transaction fees to its partner companies. Moreover, the company has not been able to provide any feedback or explanation regarding this situation. As for the Solana purchase, it seems that former CEO Robert Lim spread false hype before stepping down and profited together with whales. This is because ISPC is clearly not in a financial position to make such a purchase, and in reality, it has not even attempted to do so.
2 · Reply
haydenjc
haydenjc Jan. 7 at 2:20 PM
$ISPC can we at least hold .30. Smdh
0 · Reply
JohnTrack
JohnTrack Jan. 7 at 4:09 AM
$ISPC watching if dips get bought...
0 · Reply
JohnTrack
JohnTrack Jan. 7 at 1:50 AM
$ISPC wire lit up... https://www.rapidticker.com/news/ispc-sec-filing-42bfca
0 · Reply
suredubb
suredubb Jan. 6 at 9:30 PM
$ISPC close to a bottom.. bought 60,000 shares good time to scale in.. this stock is going up
0 · Reply
michaelmason
michaelmason Jan. 6 at 5:31 PM
$ISPC they did the offering to pay a big PR firm because they have an announcement coming. Will likely be crypto related.
0 · Reply
JohnTrack
JohnTrack Jan. 5 at 10:20 PM
$ISPC consulting agreement, is it needed at that cost? https://www.rapidticker.com/news/ispc-sec-filing-db4d09
1 · Reply
topstockalerts
topstockalerts Jan. 5 at 9:45 PM
After Hours Top Gainers $CYCN $KALA $LHSW $ISPC $HUIZ
0 · Reply
ieatbaguette
ieatbaguette Jan. 5 at 9:28 PM
$ISPC been watching this pos since ipo 5? Years ago.... That post Craig hallum was so keen on this stock but it's done absolutely nothing but tank Maybe solana treasury will make them money finally
0 · Reply
ieatbaguette
ieatbaguette Jan. 5 at 9:21 PM
$ISPC will hit volume scanners any second
0 · Reply
ieatbaguette
ieatbaguette Jan. 5 at 9:20 PM
$ISPC someone knows something
1 · Reply